BerandaRCEL • NASDAQ
add
AVITA Medical Inc
Tutup sebelumnya
$5,75
Rentang hari
$5,75 - $6,33
Rentang tahun
$5,46 - $14,16
Kapitalisasi pasar
161,52Â jt USD
Volume Rata-Rata
300,30Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 18,51Â jt | 66,73% |
Biaya operasional | 27,51Â jt | 2,65% |
Laba bersih | -13,86Â jt | 25,72% |
Margin laba bersih | -74,86 | 55,45% |
Penghasilan per saham | -0,83 | 25,24% |
EBITDA | -11,31Â jt | 33,51% |
Tarif pajak efektif | -0,06% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 25,82Â jt | -62,13% |
Total aset | 69,56Â jt | -28,57% |
Total liabilitas | 74,13Â jt | 14,37% |
Total ekuitas | -4,57 jt | — |
Saham yang beredar | 26,43 jt | — |
Harga terhadap nilai buku | -33,82 | — |
Tingkat pengembalian aset | -39,62% | — |
Tingkat pengembalian modal | -65,72% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -13,86Â jt | 25,72% |
Kas dari operasi | -10,31Â jt | 50,59% |
Kas dari investasi | 10,77Â jt | -28,54% |
Kas dari pembiayaan | 363,00Â rb | -42,47% |
Perubahan kas bersih | 820,00Â rb | 115,87% |
Arus kas bebas | -2,52Â jt | 82,32% |
Tentang
Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia. Wikipedia
Didirikan
1999
Kantor pusat
Situs
Karyawan
260
